Biodexa Pharmaceuticals

BDRX · NASDAQ

$0.4233+$0.0093 (+2.25%)TodayMarket closed · Oct 23, 7:49 PM ET

Prev close $0.414

Latest news

Press releaseOct 13, 8:30 AM ETGlobe Newswire
Biodexa announces another Serenta milestone with 100 patients enrolled in its registrational Phase 3 trial in FAP
Press releaseSep 23, 6:30 AM ETACCESS Newswire
The Longview: Fireside Chat with Biodexa CEO Stephen Stamp
NewsSep 17, 1:05 PM ET
12 Health Care Stocks Moving In Thursday's Intraday Session
NewsSep 17, 8:05 AM ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
NewsSep 16, 1:05 PM ET
12 Health Care Stocks Moving In Wednesday's Intraday Session
NewsSep 15, 8:05 AM ET
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
NewsSep 11, 5:06 PM ET
12 Health Care Stocks Moving In Friday's After-Market Session
Press releaseSep 11, 4:30 PM ETGlobe Newswire
Interim results for the six months ended June 30, 2026
NewsAug 26, 1:06 PM ET
12 Health Care Stocks Moving In Wednesday's Intraday Session
NewsAug 25, 5:06 PM ET
12 Health Care Stocks Moving In Tuesday's After-Market Session
NewsAug 25, 8:06 AM ET
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
NewsAug 25, 5:25 AM ETAvi Kapoor
Why Cadeler Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
Press releaseAug 19, 8:30 AM ETGlobe Newswire
Biodexa announces major milestone for its Serenta registrational Phase 3 trial in FAP
NewsJul 29, 5:06 PM ET
12 Health Care Stocks Moving In Wednesday's After-Market Session
NewsJul 23, 5:06 PM ET
12 Health Care Stocks Moving In Thursday's After-Market Session
NewsJul 22, 5:05 PM ET
12 Health Care Stocks Moving In Wednesday's After-Market Session
NewsMay 5, 8:06 AM ET
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
NewsApr 7, 5:20 AM ETAvi Kapoor
Why Silo Pharma Shares Are Trading Higher By Around 52%; Here Are 20 Stocks Moving Premarket
Press releaseMar 27, 5:00 PM ETGlobe Newswire
Preliminary Results for the Year Ended 31 December 2025
Press releaseFeb 19, 7:30 AM ETACCESS Newswire
Biodexa Licenses Phase 1 Ready Drug Candidate from Otsuka for Rare Stomach Cancer
Press releaseFeb 4, 8:30 AM ETGlobe Newswire
Biodexa Announces Exclusive License of Otsuka's OPB-171775, a potent Phase 1 ready Molecular Glue for GIST
NewsDec 11, 4:05 PM ET
12 Health Care Stocks Moving In Thursday's After-Market Session
NewsDec 10, 5:00 AM ETAvi Kapoor
Why Braze Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
NewsNov 24, 4:05 PM ET
12 Health Care Stocks Moving In Monday's After-Market Session
NewsNov 18, 12:06 PM ET
12 Health Care Stocks Moving In Tuesday's Intraday Session
NewsNov 18, 7:06 AM ET
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Press releaseNov 3, 8:30 AM ETGlobe Newswire
Biodexa Announces Approval of CTA in Europe for Phase 3 Serenta Trial in FAP First European patient expected to be enrolled in 4Q 2025 Addressable US - European Market Put at $7 Billion
Press releaseSep 12, 8:30 AM ETGlobe Newswire
Interim results for the six months ended June 30, 2025
NewsJun 18, 1:06 PM ET
12 Health Care Stocks Moving In Wednesday's Intraday Session
NewsJun 18, 7:29 AM ET
Market-Moving News for June 18th
Press releaseJun 18, 7:00 AM ETACCESS Newswire
Biodexa Hits Key Milestone For Its Type 1 Diabetes Candidate Tolimidone, Enrolls First Patient In Phase 2a Study
NewsMay 19, 5:05 PM ET
12 Health Care Stocks Moving In Monday's After-Market Session
Press releaseApr 11, 8:30 AM ETGlobe Newswire
Preliminary Results for the Year Ended 31 December 2024
NewsApr 2, 5:05 PM ET
12 Health Care Stocks Moving In Wednesday's After-Market Session
NewsMar 20, 1:06 PM ET
12 Health Care Stocks Moving In Thursday's Intraday Session
NewsMar 19, 1:06 PM ET
12 Health Care Stocks Moving In Wednesday's Intraday Session
NewsFeb 12, 7:33 AM ET
Biodexa Wins FDA Fast Track for eRapa, Targets Familial Adenomatous Polyposis Treatment
Press releaseFeb 12, 7:30 AM ETACCESS Newswire
Following Positive Phase 2 Results and Orphan Drug Designation, Biodexa's FAP Drug Receives FDA Fast Track Status
NewsFeb 10, 2:25 PM ETAvi Kapoor
Crude Oil Rises Sharply; Manhattan Associates Shares Slide
NewsFeb 10, 12:05 PM ETAvi Kapoor
Nasdaq Surges 1%; ON Semiconductor Shares Plunge Following Earnings Miss
NewsFeb 10, 10:20 AM ETAvi Kapoor
Dow Gains 100 Points; McDonald's Shares Rise After Q4 Results
Press releaseNov 18, 9:12 PM ETPRNewswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biodexa Pharmaceuticals Plc - BDRX
Press releaseNov 2, 12:00 PM ETPRNewswire
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biodexa Pharmaceuticals Plc - BDRX
Press releaseOct 29, 4:00 PM ETGlobe Newswire
BDRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Biodexa Pharmaceuticals Plc and Encourages Investors to Contact the Firm
Press releaseOct 28, 4:00 PM ETBusiness Wire
BDRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Into Biodexa Pharmaceuticals Plc and Encourages Investors to Contact the Firm
Press releaseOct 27, 4:00 PM ETPRNewswire
BDRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Biodexa Pharmaceuticals Plc and Encourages Investors to Contact the Firm

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Biodexa announces another Serenta milestone with 100 patients enrolled in its registrational Phase 3 trial in FAP

The Longview: Fireside Chat with Biodexa CEO Stephen Stamp

12 Health Care Stocks Moving In Thursday's Intraday Session

12 Health Care Stocks Moving In Thursday's Pre-Market Session

12 Health Care Stocks Moving In Wednesday's Intraday Session

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

12 Health Care Stocks Moving In Friday's After-Market Session

Interim results for the six months ended June 30, 2026

12 Health Care Stocks Moving In Wednesday's Intraday Session

12 Health Care Stocks Moving In Tuesday's After-Market Session

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Why Cadeler Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket

Biodexa announces major milestone for its Serenta registrational Phase 3 trial in FAP

12 Health Care Stocks Moving In Wednesday's After-Market Session

12 Health Care Stocks Moving In Thursday's After-Market Session

12 Health Care Stocks Moving In Wednesday's After-Market Session

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Why Silo Pharma Shares Are Trading Higher By Around 52%; Here Are 20 Stocks Moving Premarket

Preliminary Results for the Year Ended 31 December 2025

Biodexa Licenses Phase 1 Ready Drug Candidate from Otsuka for Rare Stomach Cancer

Biodexa Announces Exclusive License of Otsuka's OPB-171775, a potent Phase 1 ready Molecular Glue for GIST

12 Health Care Stocks Moving In Thursday's After-Market Session

Why Braze Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket

12 Health Care Stocks Moving In Monday's After-Market Session

12 Health Care Stocks Moving In Tuesday's Intraday Session

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Biodexa Announces Approval of CTA in Europe for Phase 3 Serenta Trial in FAP First European patient expected to be enrolled in 4Q 2025 Addressable US - European Market Put at $7 Billion

Interim results for the six months ended June 30, 2025

12 Health Care Stocks Moving In Wednesday's Intraday Session

Market-Moving News for June 18th

Biodexa Hits Key Milestone For Its Type 1 Diabetes Candidate Tolimidone, Enrolls First Patient In Phase 2a Study

12 Health Care Stocks Moving In Monday's After-Market Session

Preliminary Results for the Year Ended 31 December 2024

12 Health Care Stocks Moving In Wednesday's After-Market Session

12 Health Care Stocks Moving In Thursday's Intraday Session

12 Health Care Stocks Moving In Wednesday's Intraday Session

Biodexa Wins FDA Fast Track for eRapa, Targets Familial Adenomatous Polyposis Treatment

Following Positive Phase 2 Results and Orphan Drug Designation, Biodexa's FAP Drug Receives FDA Fast Track Status

Crude Oil Rises Sharply; Manhattan Associates Shares Slide

Nasdaq Surges 1%; ON Semiconductor Shares Plunge Following Earnings Miss

Dow Gains 100 Points; McDonald's Shares Rise After Q4 Results

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biodexa Pharmaceuticals Plc - BDRX

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biodexa Pharmaceuticals Plc - BDRX

BDRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Biodexa Pharmaceuticals Plc and Encourages Investors to Contact the Firm

BDRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Into Biodexa Pharmaceuticals Plc and Encourages Investors to Contact the Firm

BDRX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Biodexa Pharmaceuticals Plc and Encourages Investors to Contact the Firm